PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-May-2026 BioInvent to Present Clinical Data on FcγRIIB Antibody BI-1206 Triplet Combination Therapy with rituximab and Calquence(R) in Relapsed/Refractory NHL at EHA 2026 ACCESS Newswire
12-May-2026 Medical Care Technologies (OTC PINK:MDCE) Targets Additional $100K-$200K Asset Monetization Through Infinite Auctions Flash Event ACCESS Newswire
12-May-2026 CEO Statement to Shareholders ACCESS Newswire
12-May-2026 1upHealth Leads Industry in CMS-0057 Readiness with All Health Plan Customers Reporting Ahead of Deadline ACCESS Newswire
12-May-2026 enVVeno Medical Discusses FDA IDE Approval in Virtual Investor "What This Means" Segment ACCESS Newswire
12-May-2026 Repair Biotechnologies Granted Rare Disease Evidence Principles (RDEP) Eligibility by the FDA for REP-0003 in Homozygous Familial Hypercholesterolemia ACCESS Newswire
12-May-2026 QIAGEN plant die Ernennung von Dr. Metin Colpan zum Ehrenvorsitzenden des Aufsichtsrats, setzt die Neuausrichtung der Aufsichtsratsstruktur fort und schlägt höhere Kapitalrückzahlungen auf der Hauptversammlung 2026 vor Businesswire
12-May-2026 QIAGEN to Appoint Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, Continue Governance Renewal and Propose Increased Returns at 2026 Annual General Meeting Businesswire
12-May-2026 Oncopeptides intends to submit type II variation to expand Pepaxti label to include third line treatment Oncopeptides
12-May-2026 Poolbeg Pharma plc - POLB 001 cancer immunotherapy-induced CRS patent granted in Canada Poolbeg Pharma
12-May-2026 ENA Respiratory Successfully Completes First Part of Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections ENA Respiratory
12-May-2026 VIVEbiotech Expands Lentiviral Vector Manufacturing Capabilities with EvoLVcell VIVEbiotech
12-May-2026 EktaH Shows ~50% Reduction in Post-GLP-1 Weight Rebound with Novel Obesity Treatment and Reports Positive Phase I Data EktaH SAS
12-May-2026 AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases AGC Biologics
12-May-2026 NICE issues Final Draft Guidance recommending that RYBREVANT®▼(amivantamab) with carboplatin and pemetrexed can be used during a managed access period for untreated advanced non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) exon 20 insertion mutations in adults Johnson & Johnson
12-May-2026 Exciva appoints distinguished biopharma leader Mark Altmeyer as chairman of the board Exciva
12-May-2026 AstronauTx builds executive team with appointment of experienced clinical development leader Michelle Mellion, MD as Chief Medical Officer AstronauTx
12-May-2026 ViCentra Announces Commercial Launch of New Smartphone-Controlled Kaleido Automated Insulin Delivery Patch Pump System ViCentra
12-May-2026 Ensysce Biosciences Announces Expansion of Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology ACCESS Newswire
12-May-2026 DEA's New Marijuana Registration Questions Redefining the Cannabis Industry - And MMJ International Already Has the Answer ACCESS Newswire